Blockchain Genomics Firm, Global Pharma Giant Merck Sign Anonymized Data Sharing Agreement

As previously reported, Nebula is a blockchain-powered platform for genome-sequencing data, co-founded in 2017 by renowned geneticist Professor George Church and his Harvard colleagues Dennis Grishin and Kamal Obbad.The platform leverages blockchain technology in a bid to incentivize genomic data generation and sharing, and to lower the costs of genome-sequencing while preserving privacy and individuals’ control over their unique and sensitive data.In its collaboration with EDM Serono, Nebula will provide the firm with access to its network of anonymized genomic data in order to support the research and development of new medicines.In January of this year, Merck was  awarded  a  patent in the United States earlier this year for a system that uses a combination of artificial intelligence and blockchain tech to establish the authenticity of unique physical objects.

Leave a comment